Ridwan Shabsigh

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi Female sexual dysfunction, voiding symptoms and depression: common findings in partners of men with erectile dysfunction
    Ridwan Shabsigh
    Department of Urology, College of Physicians and Surgeons of Columbia University, Atchley Pavilion, 11th Floor, 161 Fort Washington Ave, New York, NY 10032, USA
    World J Urol 24:653-6. 2006
  2. ncbi Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone
    R Shabsigh
    Department of Urology, Columbia University, New York, New York 10032, USA
    J Urol 172:658-63. 2004
  3. ncbi Drivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countries
    Ridwan Shabsigh
    Department of Urology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    BJU Int 94:1055-65. 2004
  4. ncbi Health issues of men: prevalence and correlates of erectile dysfunction
    R Shabsigh
    Department of Urology, Columbia University, New York, New York 10032, USA
    J Urol 174:662-7. 2005
  5. ncbi Cardiovascular issues in hypogonadism and testosterone therapy
    Ridwan Shabsigh
    Department of Urology, College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA
    Am J Cardiol 96:67M-72M. 2005
  6. ncbi Testosterone therapy in erectile dysfunction and hypogonadism
    Ridwan Shabsigh
    Department of Urology, Columbia University, New York, NY 10032, USA
    J Sex Med 2:785-92. 2005
  7. ncbi Diagnosing premature ejaculation: a review
    Ridwan Shabsigh
    Urology, Columbia University, New York, NY 10032, USA
    J Sex Med 3:318-23. 2006
  8. ncbi The evolving role of testosterone in the treatment of erectile dysfunction
    R Shabsigh
    Department of Urology, Columbia University, New York, NY 10032, USA
    Int J Clin Pract 60:1087-92. 2006
  9. ncbi Understanding the needs and objectives of erectile dysfunction patients
    Ridwan Shabsigh
    Department of Urology, New York Center of Human Sexuality, Columbia University College of Physicians and Surgeons, 161 Fort Washington Avenue, Dana Atchley Pavilion, 11th Floor, New York, NY 10032, USA
    World J Urol 24:618-22. 2006
  10. ncbi Erectile dysfunction
    Ridwan Shabsigh
    Department of Urology, Columbia University College of Physicians and Surgeons, 161 Fort Washington Avenue, New York, New York 10032, USA
    Annu Rev Med 54:153-68. 2003

Detail Information

Publications80

  1. ncbi Female sexual dysfunction, voiding symptoms and depression: common findings in partners of men with erectile dysfunction
    Ridwan Shabsigh
    Department of Urology, College of Physicians and Surgeons of Columbia University, Atchley Pavilion, 11th Floor, 161 Fort Washington Ave, New York, NY 10032, USA
    World J Urol 24:653-6. 2006
    ..Urinary symptoms of frequency and urgency were reported by 18/50 (36%). Depressive symptoms were present in 22/50 (44%). FSD disorders, urinary symptoms and depressive symptoms are common in partners of men with erectile dysfunction...
  2. ncbi Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone
    R Shabsigh
    Department of Urology, Columbia University, New York, New York 10032, USA
    J Urol 172:658-63. 2004
    ..We compare the efficacy of testosterone gel (T-gel) versus placebo as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone...
  3. ncbi Drivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countries
    Ridwan Shabsigh
    Department of Urology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    BJU Int 94:1055-65. 2004
    ..Although the prevalence and epidemiology of ED have been reviewed, there is little information about the treatment-seeking behaviour of men with this disorder...
  4. ncbi Health issues of men: prevalence and correlates of erectile dysfunction
    R Shabsigh
    Department of Urology, Columbia University, New York, New York 10032, USA
    J Urol 174:662-7. 2005
    ..The prevalence of erectile dysfunction (ED) and its correlation with patient age, overall health and comorbidities were assessed...
  5. ncbi Cardiovascular issues in hypogonadism and testosterone therapy
    Ridwan Shabsigh
    Department of Urology, College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA
    Am J Cardiol 96:67M-72M. 2005
    ..Further research on the cardiovascular benefits and risks of testosterone is strongly recommended...
  6. ncbi Testosterone therapy in erectile dysfunction and hypogonadism
    Ridwan Shabsigh
    Department of Urology, Columbia University, New York, NY 10032, USA
    J Sex Med 2:785-92. 2005
    ..In humans, testosterone therapy improves erectile function in men with hypogonadism. However, the efficacy of testosterone monotherapy may not be adequate because of the multifactorial nature of the pathophysiology of ED...
  7. ncbi Diagnosing premature ejaculation: a review
    Ridwan Shabsigh
    Urology, Columbia University, New York, NY 10032, USA
    J Sex Med 3:318-23. 2006
    ..Patients fail to seek medical help because of the stigma and embarrassment over the condition. In addition, patients (and clinicians) often misdiagnose PE as erectile dysfunction (ED)...
  8. ncbi The evolving role of testosterone in the treatment of erectile dysfunction
    R Shabsigh
    Department of Urology, Columbia University, New York, NY 10032, USA
    Int J Clin Pract 60:1087-92. 2006
    ..Screening for hypogonadism may be useful in men with ED who fail prior PDE5 inhibitors, especially in populations at risk for hypogonadism such as type 2 diabetes and the metabolic syndrome...
  9. ncbi Understanding the needs and objectives of erectile dysfunction patients
    Ridwan Shabsigh
    Department of Urology, New York Center of Human Sexuality, Columbia University College of Physicians and Surgeons, 161 Fort Washington Avenue, Dana Atchley Pavilion, 11th Floor, New York, NY 10032, USA
    World J Urol 24:618-22. 2006
    ..These barriers have had a negative impact on the ED patient and marketplace resulting in low rates of utilization and high rates of dropout from therapies for ED...
  10. ncbi Erectile dysfunction
    Ridwan Shabsigh
    Department of Urology, Columbia University College of Physicians and Surgeons, 161 Fort Washington Avenue, New York, New York 10032, USA
    Annu Rev Med 54:153-68. 2003
    ..Management options, including traditional therapeutic approaches as well as the new generation of oral agents, are also presented...
  11. ncbi Sexual dysfunction and depression: etiology, prevalence, and treatment
    R Shabsigh
    Department of Urology, Columbia Presbyterian Medical Center, 161 Fort Washington Avenue, New York, NY 10032, USA
    Curr Urol Rep 2:463-7. 2001
    ..Research is progressing on the possible link between andropause, sexual dysfunction, and depression, thus opening potential new opportunities to address issues of aging-related morbidities...
  12. ncbi Socioeconomic considerations in erectile dysfunction treatment
    R Shabsigh
    Department of Urology, Columbia University, New York, New York, USA
    Urol Clin North Am 28:417-22. 2001
    ..The population of patients presenting for treatment of erectile dysfunction has expanded significantly and rapidly. This article addresses the descriptive and analytic economic implications of erectile dysfunction treatment...
  13. ncbi Recent developments in male sexual dysfunction
    R Shabsigh
    Department of Urology, Columbia Presbyterian Medical Center, 161 Fort Washington Avenue, New York, NY 10032, USA
    Curr Psychiatry Rep 2:196-200. 2000
    ..Some of these new medications, such as sublingual apomorphine, have a central mode of action, whereas others, such as the phosphodiesterase inhibitor IC351, have a selective peripheral vasodilation-enhancing action...
  14. ncbi Hypogonadism and erectile dysfunction: the role for testosterone therapy
    R Shabsigh
    Department of Urology, Columbia Presbyterian Medical Center, New York 10032, USA
    Int J Impot Res 15:S9-13. 2003
    ..This opens the possibility of other combinations of testosterone and other treatments of ED. The ability to exploit multiple pathways in the physiologic processes leading to erection may help improve therapy for ED...
  15. ncbi Quality of life aspects in kidney cancer patients: data from a national registry
    Aristotelis G Anastasiadis
    Department of Urology, College of Physicians and Surgeons of Columbia University, 161 Fort Washington Avenue, Herbert Irving Pavilion, New York, NY 10032, USA
    Support Care Cancer 11:700-6. 2003
    ..Quality of life and sexual function issues should be addressed when counseling urological cancer patients...
  16. ncbi Review of time of onset and duration of clinical efficacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction
    Ridwan Shabsigh
    Department of Urology, Columbia-Presbyterian Medical Center, New York, New York 10032, USA
    Urology 68:689-96. 2006
  17. ncbi PDE-5 inhibitors: current status and future trends
    Puneet Masson
    Department of Urology, College of Physicians and Surgeons, Columbia University, 161 Fort Washington Avenue, New York, NY 10032, USA
    Urol Clin North Am 32:511-25, viii. 2005
    ..The future of PDE-5 inhibitors includes the expansion of indications such as the treatment of pulmonary hypertension and the potential of treatment of symptomatic BPH...
  18. ncbi Lack of awareness of erectile dysfunction in many men with risk factors for erectile dysfunction
    Ridwan Shabsigh
    Maimonides Medical Center, Brooklyn, NY, and Columbia University, New York, NY, USA
    BMC Urol 10:18. 2010
    ....
  19. ncbi Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer
    Aristotelis G Anastasiadis
    Department of Urology, Columbia University Health Sciences, 161 Fort Washington Avenue, Herbert Irving Pavilion, 11th Floor, New York, NY 10032, USA
    J Cancer Res Clin Oncol 129:676-82. 2003
    ..More information regarding QoL is necessary for appropriate patient counseling and individual decision-making in the presence of various treatment alternatives...
  20. ncbi Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data
    Ridwan Shabsigh
    Columbia University, New York, NY, USA
    Curr Med Res Opin 23:2453-60. 2007
    ..To review the evidence evaluating the efficacy of vardenafil in subgroups of hypertensive patients with erectile dysfunction (ED)...
  21. ncbi Management of an enlarged median lobe with ureteral orifices at the margin of bladder neck during robotic-assisted laparoscopic prostatectomy
    Jamil Rehman
    Department of Urology, SUNY Stony Brook University Health Sciences Center, School of Medicine, Stony Brook, New York 11794 8093, USA
    Can J Urol 16:4490-4. 2009
    ..To present our technique for the management of an enlarged median lobe when the ureteral orifices are close to the bladder neck during robotic-assisted radical prostatectomy...
  22. ncbi Attitudes of men with erectile dysfunction: a cross-national survey
    Michael Perelman
    Weill Medical College of Cornell University Psychiatry, Reproductive Medicine, and Urology, New York, NY 10021, USA
    J Sex Med 2:397-406. 2005
    ..Erectile dysfunction (ED), the inability to achieve or maintain an erection sufficient for sexual performance, is a complex disorder involving multiple biopsychosocial factors...
  23. ncbi Hormonal factors in female sexual dysfunction
    Aristotelis G Anastasiadis
    Department of Urology, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    Curr Opin Urol 12:503-7. 2002
    ..This review presents the role of estrogen and androgens in sexual function and their potential roles as therapeutic agents for female sexual dysfunction...
  24. ncbi Hypogonadism and metabolic syndrome: implications for testosterone therapy
    Nawras Makhsida
    Department of Urology, Columbia University, New York, New York, USA
    J Urol 174:827-34. 2005
    ..Future research in the form of randomized clinical trials should focus on further defining the role of testosterone for metabolic syndrome...
  25. ncbi Erectile dysfunction and men's health: developing a comorbidity risk calculator
    Ridwan Shabsigh
    Division of Urology, Maimonides Medical Center, Brooklyn, New York, NY 07470, USA
    J Sex Med 5:1237-43. 2008
    ..Aim. To generate a calculator to predict the risk of diabetes, hypertension, hyperlipidemia or angina in men with ED, based on an analysis of data from the Men's Attitudes to Life Events and Sexuality (MALES) 2004 study...
  26. ncbi Robotic radical prostatectomy in patients with preexisting inflatable penile prosthesis (IPP)
    Jamil Rehman
    Department of Urology, School of Medicine, SUNY Stony Brook Health Sciences Center, Stony Brook, New York 11794 8093, USA
    Can J Urol 15:4263-5. 2008
    ..We present our initial experience with performing robotic-assisted prostatectomies in men with a 3-piece inflatable penile prosthesis with a pelvic reservoir...
  27. ncbi Urologic aspects of andropause
    Sameer N Stas
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Urology 61:261-6. 2003
  28. ncbi Testosterone therapy in erectile dysfunction
    R Shabsigh
    Department of Urology, Columbia University, New York, NY 10032, USA
    Aging Male 7:312-8. 2004
    ..Consequently, it is important to screen for hypogonadism in men who fail PDE5 inhibitors...
  29. ncbi The epidemiology and definition of female sexual disorders
    Aristotelis G Anastasiadis
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    World J Urol 20:74-8. 2002
    ..However, research efforts in the field are increasing. This overview presents currently used classification systems, recently updated definitions, as well as prevalence data on the different entities of female sexual disorders...
  30. ncbi Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine
    Ridwan Shabsigh
    Division of Urology, Maimonides Medical Center, Columbia University, New York, NY 11219, USA
    BJU Int 102:824-8. 2008
    ....
  31. ncbi Economic aspects of medical erectile dysfunction therapies
    Aristotelis G Anastasiadis
    Department of Urology, College of Physicians and Surgeons of Columbia University, 161 Fort Washington Avenue, Dana Atchley Pavilion, 11th Floor, New York, NY 10032, USA
    Expert Opin Pharmacother 3:257-63. 2002
    ..This article highlights the various oral, intracavernosal and intraurethral therapies currently available for ED and evaluates the socio-economic impact of each method...
  32. ncbi Therapy of ED: PDE-5 Inhibitors
    Ridwan Shabsigh
    The Department of Urology, College of Physicians and Surgeons of Columbia Universiy, New York, NY, USA
    Endocrine 23:135-41. 2004
    ..The major difference in the three approved inhibitors is that tadalafil has a considerably longer serum half-life, which provides a longer window of opportunity and potentially side effects...
  33. ncbi Long-term outcomes of inflatable penile implants: reliability, patient satisfaction and complication management
    A G Anastasiadis
    Department of Urology, College of Physicians and Surgeons, Columbia University, New York, USA
    Curr Opin Urol 11:619-23. 2001
    ..This review focuses on the most recent and important updates regarding product enhancements, patient satisfaction studies, and management of intra- and postoperative problems...
  34. ncbi The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease
    Ajay Nehra
    Department of Urology, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 87:766-78. 2012
    ....
  35. ncbi Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy
    H Padma-Nathan
    Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Int J Impot Res 20:479-86. 2008
    ..0156, Fisher's exact test) of the sildenafil group. Nightly sildenafil administration for 36 weeks after surgery markedly increased the return of normal spontaneous erections...
  36. ncbi Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials
    Ridwan Shabsigh
    Department of Urology, Columbia University, New York, NY 10032, USA
    BJU Int 96:857-63. 2005
    ....
  37. ncbi Comparison of a new length measurement technique for inflatable penile prosthesis implantation to standard techniques: outcomes and patient satisfaction
    Gerard Henry
    Department of Urology, Regional Urology, Shreveport, LA 71106, USA
    J Sex Med 8:2640-6. 2011
    ....
  38. ncbi Female sexual dysfunction: state of the art
    Aristotelis G Anastasiadis
    Department of Urology, College of Physicians and Surgeons of Columbia University, 161 Fort Washington Avenue, Herbert Irving Pavilion, 11th Floor, New York, NY 10032, USA
    Curr Urol Rep 3:484-91. 2002
    ..This review discusses the updated classification systems and definitions, epidemiologic aspects, and new pathophysiologic and therapeutic implications of this sexual disorder...
  39. ncbi Sexual dysfunction is common and overlooked in female patients with hypertension
    Martin Burchardt
    Department of Urology, College of Physicians and Surgeons of Columbia University, New York, New York, USA
    J Sex Marital Ther 28:17-26. 2002
    ..In spite of the high prevalence of sexual dysfunction, more than a third of patients reported sexual activity to be less than desired, and more than half of patients reported sexual activity as important...
  40. ncbi The influence of vaginal bleeding on the sexual behavior of urban, Hispanic women and men
    A R Davis
    Department OB GYN, New York Presbyterian Hospital, New York, NY, USA
    Contraception 65:351-5. 2002
    ..001). The presence of vaginal bleeding or spotting is associated with decreases in genital sexual behaviors among urban, Hispanic women and men. Such disruptions in sexual behavior could contribute to contraceptive discontinuation...
  41. ncbi Prevalence of and recent developments in female sexual dysfunction
    R Shabsigh
    Department of Urology, Columbia Presbyterian Medical Center, 161 Fort Washington Avenue, New York, NY 10032, USA rs
    Curr Psychiatry Rep 3:188-94. 2001
    ..Once triggered, female sexual dysfunction research went even further and raised more questions. This article addresses the prevalence of FSD and the most recent developments in this field...
  42. ncbi Efficacy, safety, and use of sildenafil in urologic practice
    E Fagelman
    Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Urology 57:1141-4. 2001
    ..CONCLUSIONS: Sildenafil is an effective and safe drug in the treatment of erectile dysfunction. At the first and second follow-up visit, most patients requested and received renewal...
  43. ncbi Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate
    S N Seidman
    Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Am J Psychiatry 158:1623-30. 2001
    ....
  44. ncbi Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha)
    Aristotelis G Anastasiadis
    The Department of Urology, College of Physicians and Surgeons, Columbia University, Atchley Pavilion, 11th Floor, 161 Fort Washington Avenue, New York, NY 10032, USA
    J Cancer Res Clin Oncol 128:358-62. 2002
    ..We sequenced HIF-1alpha cDNAs amplified from human prostate cancer cell lines and from hormone resistant prostate cancer specimens to determine whether prostate cancer cells might harbor mutations within the HIF-1alpha ODD domain...
  45. ncbi From proficiency to expert, when does the learning curve for robotic-assisted prostatectomies plateau? The Columbia University experience
    David Samadi
    Department of Urology, Columbia University, 161 Fort Washington Avenue, New York, NY, USA
    World J Urol 25:105-10. 2007
    ..Proficiency is achieved within the first 20 cases; however surgical outcomes continue to improve for RLP throughout the first 70 cases and perhaps beyond...
  46. ncbi Sexual function following bowel vaginoplasty
    Terry W Hensle
    Department of Urology, Columbia University, College of Physicians and Surgeons, New York, New York, USA
    J Urol 175:2283-6. 2006
    ..For technical reasons we believe that colonic segments, particularly sigmoid, are preferable to small bowel. Sexual function following bowel vaginoplasty appears to be adequate and durable...
  47. ncbi Summary of the recommendations on sexual dysfunctions in men
    Tom F Lue
    Department of Urology, UCSF, San Francisco, CA, USA
    J Sex Med 1:6-23. 2004
    ..Disorders of sexual function in men include erectile dysfunction, orgasm/ejaculation disorders, priapism, and Peyronie's disease...
  48. ncbi Antibiotic coating reduces penile prosthesis infection
    Dmitry Droggin
    Department of Urology, University of Columbia, New York, NY 10032, USA
    J Sex Med 2:565-8. 2005
    ..To evaluate the efficacy of a new antibiotic-coated (rifampicin+monocycline) penile prosthesis in prevention of bacterial adhesion and reduction of penile prosthesis infection...
  49. ncbi The Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision as an appropriate diagnostic for premature ejaculation
    Ridwan Shabsigh
    Maimonides Medical Center, New York, NY, USA
    J Sex Med 4:1468-78. 2007
    ....
  50. ncbi Peyronie's disease: the epidemiology, aetiology and clinical evaluation of deformity
    Christopher J Smith
    Department of Urology, Columbia University, New York, New York, USA
    BJU Int 95:729-32. 2005
    ....
  51. ncbi The triad of erectile dysfunction, hypogonadism and the metabolic syndrome
    R Shabsigh
    Division of Urology, Maimonides Medical Center, Columbia University, Brooklyn, NY 11219, USA
    Int J Clin Pract 62:791-8. 2008
    ..Methods: An Expert Panel Meeting was held in December 2006 in Vienna, Austria. In addition a comprehensive literature search was conducted...
  52. ncbi Reliability of efficacy in men with erectile dysfunction treated with tadalafil once daily after initial success
    R Shabsigh
    Maimonides Medical Center and Columbia University, New York, NY, USA
    Int J Impot Res 22:1-8. 2010
    ..9%, P<0.001) compared to men taking placebo (70.2%). Overall, men with ED taking tadalafil once daily experienced a high rate of reliability of efficacy...
  53. ncbi Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline
    Ridwan Shabsigh
    Division of Urology, Maimonides Medical Center, New York, NY 11219, USA
    J Sex Med 10:844-56. 2013
    ..Tadalafil is efficacious and well tolerated for erectile dysfunction (ED), but effects in men with "complete ED" are unclear...
  54. ncbi Nitrofurantoin: the return of an old friend in the wake of growing resistance
    James Kashanian
    Division of Urology, Maimonides Medical Center, Brooklyn, New York, NY 11024, USA
    BJU Int 102:1634-7. 2008
    ....
  55. ncbi Daily patterns of sexual intercourse attempts by men with erectile dysfunction treated with tadalafil: influence of age and marital status
    R Shabsigh
    Division of Urology, Maimonides Medical Center and Columbia University, New York, NY 11219, USA
    Int J Impot Res 21:285-91. 2009
    ..Information regarding sexual behavioral patterns of men with ED is important to consider when discussing patient expectations...
  56. ncbi Sexual function in health and disease
    R Shabsigh
    New York Center for Human Sexuality, Columbia University, New York City, USA
    Postgrad Med 107:5-9. 2000
    ..Fortunately, new developments in the pharmacologic treatment of ED give physicians and their patients a wider and more effective array of treatment options with which to address this potentially distressing condition...
  57. ncbi Response to treatment with tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline
    R Shabsigh
    Division of Urology, Maimonides Medical Center and Columbia University, New York, NY 11219, USA
    Int J Impot Res 20:554-60. 2008
    ..Patients who are unable to have successful intercourse should be encouraged to try oral phosphodiesterase type 5 inhibitor treatment for ED...
  58. ncbi Cavernous nerve graft reconstruction during radical prostatectomy or radical cystectomy: safe and technically feasible
    A G Anastasiadis
    The Department of Urology, College of Physicians and Surgeons of Columbia University, New York 10032, USA
    Prostate Cancer Prostatic Dis 6:56-60. 2003
    ..Randomized studies with more patients and long follow-up periods are necessary in order to define the ideal candidate for nerve graft procedures...
  59. ncbi Common conditions of the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression
    L Zakaria
    Department of Urology, The College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    Int Urol Nephrol 33:283-92. 2001
    ....
  60. ncbi Expression of messenger ribonucleic acid splice variants for vascular endothelial growth factor in the penis of adult rats and humans
    M Burchardt
    Department of Urology, College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA
    Biol Reprod 60:398-404. 1999
    ..This study is a prelude to attempts to genetically manipulate VEGF expression in the penis as a therapy for erectile dysfunction...
  61. ncbi Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices
    Martin Miner
    Warren Alpert School of Medicine, Brown University, Providence, RI 02912, USA
    Postgrad Med 120:130-53. 2008
    ..If TRT is initiated, a patient's response and adverse events should be assessed every 3 to 6 months, and therapy adjusted accordingly...
  62. ncbi The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials
    Raymond C Rosen
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA
    Curr Med Res Opin 21:1701-9. 2005
    ..001). CONCLUSIONS: Compared with placebo, tadalafil 10 mg and 20 mg improved overall satisfaction with the sexual experience, intercourse satisfaction, and intercourse enjoyment in men with mild, moderate, and severe ED...
  63. ncbi Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers
    Culley Carson
    Division of Urology, University of North Carolina, Chapel Hill, North Carolina 27599-7235, USA
    Urology 65:353-9. 2005
    ..These results were observed in a tertiary-care, academic center population with a high incidence of severe, organic ED, and comorbid medical conditions, factors known to compromise erectile function and treatment outcome...
  64. ncbi Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study
    Raymond Rosen
    Department of Psychiatry, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA
    Am J Psychiatry 163:79-87. 2006
    ..The present study assessed the safety and efficacy of vardenafil in men with erectile dysfunction and untreated mild depression...
  65. ncbi Sensitivity of the psychological and interpersonal relationship scales to oral therapies for erectile dysfunction
    Raymond Rosen
    Eli Lilly and Company-Outcomes Research, Indianapolis, IN 46285, USA
    J Sex Med 2:461-8. 2005
    ..CONCLUSIONS: Mean differences observed on PAIRS domains across studies support the sensitivity of the measure to differentiate between these two ED treatments...
  66. ncbi Determining the earliest time within 30 minutes to erectogenic effect after tadalafil 10 and 20 mg: a multicenter, randomized, double-blind, placebo-controlled, at-home study
    Raymond C Rosen
    Robert Wood Johnson Medical School, Piscataway, NJ, USA
    J Sex Med 1:193-200. 2004
    ..Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor used for the treatment of erectile dysfunction (ED). The minimal time to onset of erectogenic effect in the at-home setting has not been evaluated...
  67. ncbi Is there a relationship between sex hormones and erectile dysfunction? Results from the Massachusetts Male Aging Study
    Varant Kupelian
    New England Research Institutes, 9 Galen Street, Watertown, MA 02472, USA
    J Urol 176:2584-8. 2006
    ..Simultaneously, age related changes occur in male endocrine functioning. We examined the association between erectile dysfunction and total testosterone, bioavailable testosterone, sex hormone-binding globulin and luteinizing hormone...
  68. ncbi Treating erectile dysfunction when PDE5 inhibitors fail
    Chelsea N McMahon
    St Vincent's Hospital, Darlinghurst, NSW 2010, Australia
    BMJ 332:589-92. 2006
  69. ncbi Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression
    H George Nurnberg
    Department of Psychiatry, Health Sciences Center, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131 5286, USA
    Urology 60:58-66. 2002
    ..Given the complex interrelations among ED, depression, and other comorbid conditions, the key to proper management is a comprehensive evaluation, including sexual function, and an accurate differential diagnosis...
  70. ncbi Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials
    Jon L Pryor
    University of Minnesota, Minneapolis, MN 55455, USA
    Lancet 368:929-37. 2006
    ..No drugs are approved for treatment of premature ejaculation. Our aim was to determine the efficacy and tolerability of on-demand dapoxetine in patients with severe premature ejaculation...
  71. ncbi Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)
    John B Kostis
    University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, NJ, USA
    Am J Cardiol 96:313-21. 2005
    ..Finally, further research on the role of PDE-5 inhibition in treating patients with other medical or cardiovascular disorders is recommended...
  72. ncbi Bicycle riding and its relationship to the development of erectile dysfunction
    John A Taylor
    Division of Urology, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030 3955, USA
    J Urol 172:1028-31. 2004
    ..Insufficient data have left cyclists skeptical of this claim. We explore risk factors within cycling that may put riders at risk for the development of erectile dysfunction (ED)...
  73. ncbi Application of angiogenic factors for therapy of erectile dysfunction: protein and DNA transfer of VEGF 165 into the rat penis
    Martin Burchardt
    Department of Urology, Medizinische Hochschule Hannover, Hannover, Germany
    Urology 66:665-70. 2005
    ..This study was a prelude to attempt to manipulate genetically expression of angiogenic factors in insufficient erectile tissue as a curative therapy for ED...
  74. ncbi Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes
    Ahmad Haidar
    Urologic Office, Bremerhaven, Germany
    Aging Male 10:189-96. 2007
    ..The present study monitored the effects of androgen deprivation therapy in men with insulin-dependent diabetes on glycaemic control and on biochemical cardiovascular risk markers...
  75. ncbi Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)
    John B Kostis
    University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
    Am J Cardiol 96:85M-93M. 2005
    ..Finally, further research on the role of PDE-5 inhibition in treating patients with other medical or cardiovascular disorders is recommended...
  76. ncbi The other side: failure in fair and balanced reporting
    Stanley E Althof
    J Sex Med 2:583-4. 2005
  77. ncbi Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study
    Varant Kupelian
    New England Research Institutes, 9 Galen Street, Watertown, MA 02472, USA
    J Urol 176:222-6. 2006
    ..This finding suggests that erectile dysfunction may provide a warning sign and an opportunity for early intervention in men otherwise considered at lower risk for the metabolic syndrome and subsequent cardiovascular disease...
  78. ncbi Erectile dysfunction--an observable marker of diabetes mellitus? A large national epidemiological study
    Peter Sun
    United States Medical Division, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center Drop Code 5024, Indianapolis, IN 46285, USA
    J Urol 176:1081-5; discussion 1085. 2006
    ..We examined whether men with erectile dysfunction are more likely to have diabetes mellitus than men without erectile dysfunction, and whether erectile dysfunction can be used as an observable early marker of diabetes mellitus...
  79. ncbi The Bolger conference on PDE-5 inhibition and HIV risk: implications for health policy and prevention
    Raymond C Rosen
    Department of Psychiatry, Robert Wood Johnson Medical School, Piscataway, NJ, USA
    J Sex Med 3:960-75; discussion 973-5. 2006
    ..Recent reports have linked the use of phosphodiesterase type 5 (PDE-5) inhibitors with increased rates of high-risk sexual behavior and HIV transmission in some individuals...
  80. ncbi The natural progression and remission of erectile dysfunction: results from the Massachusetts Male Aging Study
    Thomas G Travison
    New England Research Institutes, Watertown, Massachusetts 02472, USA
    J Urol 177:241-6; discussion 246. 2007
    ....